vs
Side-by-side financial comparison of T1 Energy Inc. (TE) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $210.5M, roughly 1.4× T1 Energy Inc.). Bio-Techne runs the higher net margin — 12.8% vs -62.0%, a 74.9% gap on every dollar of revenue.
Sony Energy Devices Corporation , is a Japanese multinational company specializing in a variety of areas in the energy industry, and is a wholly owned subsidiary and part of the Devices Group of Sony. The company was established in February 1975 in Fukushima, Japan.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
TE vs TECH — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $210.5M | $295.9M |
| Net Profit | $-130.6M | $38.0M |
| Gross Margin | 10.0% | 64.6% |
| Operating Margin | -45.0% | 18.4% |
| Net Margin | -62.0% | 12.8% |
| Revenue YoY | — | -6.4% |
| Net Profit YoY | -375.2% | 68.3% |
| EPS (diluted) | $-0.87 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $295.9M | ||
| Q3 25 | $210.5M | — | ||
| Q2 25 | $132.8M | $317.0M | ||
| Q1 25 | $53.5M | $316.2M | ||
| Q4 24 | — | $297.0M | ||
| Q3 24 | $0 | $289.5M | ||
| Q2 24 | $0 | $306.1M | ||
| Q1 24 | $0 | $303.4M |
| Q4 25 | — | $38.0M | ||
| Q3 25 | $-130.6M | — | ||
| Q2 25 | $-31.9M | $-17.7M | ||
| Q1 25 | $-16.2M | $22.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | $-27.5M | $33.6M | ||
| Q2 24 | $-27.0M | $40.6M | ||
| Q1 24 | $-28.5M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | 10.0% | — | ||
| Q2 25 | 24.7% | 62.7% | ||
| Q1 25 | 33.3% | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | — | 18.4% | ||
| Q3 25 | -45.0% | — | ||
| Q2 25 | -22.0% | -7.5% | ||
| Q1 25 | -44.2% | 12.2% | ||
| Q4 24 | — | 16.0% | ||
| Q3 24 | — | 13.8% | ||
| Q2 24 | — | 15.0% | ||
| Q1 24 | — | 22.1% |
| Q4 25 | — | 12.8% | ||
| Q3 25 | -62.0% | — | ||
| Q2 25 | -24.0% | -5.6% | ||
| Q1 25 | -30.4% | 7.1% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | — | 11.6% | ||
| Q2 24 | — | 13.3% | ||
| Q1 24 | — | 16.2% |
| Q4 25 | — | $0.24 | ||
| Q3 25 | $-0.87 | — | ||
| Q2 25 | $-0.21 | $-0.11 | ||
| Q1 25 | $-0.11 | $0.14 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | $-0.20 | $0.21 | ||
| Q2 24 | $-0.19 | $0.26 | ||
| Q1 24 | $-0.20 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.1M | $172.9M |
| Total DebtLower is stronger | $547.3M | $260.0M |
| Stockholders' EquityBook value | $96.9M | $2.0B |
| Total Assets | $1.4B | $2.5B |
| Debt / EquityLower = less leverage | 5.65× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $172.9M | ||
| Q3 25 | $34.1M | — | ||
| Q2 25 | $8.5M | $162.2M | ||
| Q1 25 | $48.9M | $140.7M | ||
| Q4 24 | — | $177.5M | ||
| Q3 24 | $181.9M | $187.5M | ||
| Q2 24 | $219.6M | $152.9M | ||
| Q1 24 | $249.9M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | $547.3M | — | ||
| Q2 25 | $591.2M | $346.0M | ||
| Q1 25 | $603.2M | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | $602.3M | $389.0M |
| Q4 25 | — | $2.0B | ||
| Q3 25 | $96.9M | — | ||
| Q2 25 | $183.9M | $1.9B | ||
| Q1 25 | $201.9M | $2.0B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | $538.7M | $2.1B | ||
| Q2 24 | $561.6M | $2.1B | ||
| Q1 24 | $582.3M | $2.0B |
| Q4 25 | — | $2.5B | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | $2.6B | ||
| Q1 25 | $1.4B | $2.6B | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | $615.0M | $2.7B | ||
| Q2 24 | $644.4M | $2.7B | ||
| Q1 24 | $670.3M | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | 5.65× | — | ||
| Q2 25 | 3.21× | 0.18× | ||
| Q1 25 | 2.99× | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | 1.03× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.9M | — |
| Free Cash FlowOCF − Capex | $55.0M | — |
| FCF MarginFCF / Revenue | 26.1% | — |
| Capex IntensityCapex / Revenue | 4.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-42.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $63.9M | — | ||
| Q2 25 | $33.4M | $98.2M | ||
| Q1 25 | $-44.8M | $41.1M | ||
| Q4 24 | — | $84.3M | ||
| Q3 24 | $-28.4M | $63.9M | ||
| Q2 24 | $-28.0M | $75.5M | ||
| Q1 24 | $-16.2M | $81.0M |
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | $10.6M | $93.3M | ||
| Q1 25 | $-74.0M | $31.0M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | $-34.0M | $54.7M | ||
| Q2 24 | $-35.6M | $57.5M | ||
| Q1 24 | $-37.7M | $64.5M |
| Q4 25 | — | — | ||
| Q3 25 | 26.1% | — | ||
| Q2 25 | 8.0% | 29.4% | ||
| Q1 25 | -138.4% | 9.8% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 18.9% | ||
| Q2 24 | — | 18.8% | ||
| Q1 24 | — | 21.3% |
| Q4 25 | — | — | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | 17.2% | 1.5% | ||
| Q1 25 | 54.5% | 3.2% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | 5.9% | ||
| Q1 24 | — | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TE
| Related Party | $120.1M | 57% |
| Nonrelated Party | $90.4M | 43% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
